Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112149 · ClinicalTrials.gov registry record · Phase 3
Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT02112149 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 200 participants.
The verdict
NCT02112149, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The proposed study is a randomized trial evaluating the impact of the 12-week LIVESTRONG exercise program vs. waitlist control on cancer-related outcomes in 200 cancer survivors.
Interventions
- BEHAVIORAL LIVESTRONG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112149
The ClinicalTrials.gov registry entry for NCT02112149 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LIVESTRONG is the first listed.
NCT02112149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02112149 about?
NCT02112149 is a clinical study titled "Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors". The proposed study is a randomized trial evaluating the impact of the 12-week LIVESTRONG exercise program vs. waitlist control on cancer-related outcomes in 200 cancer survivors.
What is the current status of trial NCT02112149?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2013-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02112149?
The interventions under investigation include: LIVESTRONG (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112149?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.